MOTILIUM

This brand name is authorized in Australia, Austria, Brazil, Cyprus, Ecuador, France, Germany, Hong Kong SAR China, Ireland, Israel, Lithuania, Malta, Mexico, Netherlands, New Zealand, Nigeria, Romania, Singapore, South Africa, Spain, Turkey, UK.

Active ingredients

The drug MOTILIUM contains one active pharmaceutical ingredient (API):

1	Domperidone UNII 5587267Z69 - DOMPERIDONE
	Domperidone is a dopamine antagonist with anti-emetic properties, Domperidone does not readily cross the blood-brain barrier. In domperidone users, especially in adults, extrapyramidal side effects are very rare, but domperidone promotes the release of prolactin from the pituitary.
	Read more about Domperidone

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
MOTILIUM Film-coated tablet	MPI, EU: SmPC	Medicines & Healthcare Products Regulatory Agency (GB)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
A03FA03	Domperidone	A Alimentary tract and metabolism → A03 Drugs for functional gastrointestinal disorders → A03F Propulsives → A03FA Propulsives
Discover more medicines within A03FA03

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
AU	Pharmaceutical Benefits Scheme	1347X
BR	Câmara de Regulação do Mercado de Medicamentos	514502401135317, 514502403111318, 514502404118316, 514502405130311, 514502406137318, 514502407117310, 514512020024803
DE	Bundesinstitut für Arzneimittel und Medizinprodukte	01693376, 01693407, 02084550, 02334202, 02334219, 02739979, 03050843, 03050866
EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	27.253-09-06
ES	Centro de información online de medicamentos de la AEMPS	55410, 55411
FR	Base de données publique des médicaments	63679194, 69742865
GB	Medicines & Healthcare Products Regulatory Agency	15659, 15662
HK	Department of Health Drug Office	48305
IE	Health Products Regulatory Authority	74284
IL	מִשְׂרַד הַבְּרִיאוּת	4332
LT	Valstybinė vaistų kontrolės tarnyba	1011620, 1011621, 1034132, 1068246, 1080373, 1087568, 1088479, 1090112
MT	Medicines Authority	AA521/02004, AA908/04804, MA1471/00501, PI908/04801A
MX	Comisión Federal para la Protección contra Riesgos Sanitarios	0041M79, 0042M79
NG	Registered Drug Product Database	04-1293
Switch country to Nigeria in order to find specific presentations of MOTILIUM
NL	Z-Index G-Standaard	12134171
NL	Z-Index G-Standaard, PRK	6289
NZ	Medicines and Medical Devices Safety Authority	3558
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W12227001, W12227002
SG	Health Sciences Authority	02500P, 02891P
TR	İlaç ve Tıbbi Cihaz Kurumu	8699593095382, 8699593701054
ZA	Health Products Regulatory Authority	K/5.7.2/261, V/5.7.2/19